UC Davis Health’s IFM Fund Backs Delix Therapeutics in First Investment
Quick Summary
- UC Davis Health Ventures, part of the Innovation and Economic Development Office (IEDO) at the University of California, Davis, today announced the first investment from its Investing in the Future of Medicine (IFM) Fund, backing Delix Therapeutics.